X.-W. Li et al. / Inorganica Chimica Acta 378 (2011) 280–287
281
Elemental analyses (C, H and N) were carried out on a Perkin–
Elmer 240C analytic instrument. IR spectra were performed on a
Nicolet NEXUS870 FT-IR spectrometer. The catalytic data were col-
lected by GC-9560 equipment.
ylidene H), 7.48 (s, 1H, 4,5-imidazol-2-ylidene H), 5.84 (s, 2H,
CH2 linker), 4.02 (s, 3H, CH3). 13C NMR (DMSO-d6, 125 MHz): d
200.05, 192.94 (CO), 175.18 (Ru–C), 157.47, 156.04, 140.95,
126.33, 125.57, 123.90, 122.67 (Py–C and Ar–C), 53.34(CH2),
37.80(CH3). Anal. Calc. for C12H11N3O2Cl2Ru: C, 35.92; H, 2.76; N,
10.47. Found: C, 36.04; H, 2.74; N, 10.24%. FT-IR (KBr, cmꢀ1): mCO
2.2. Synthesis of compounds
2044 and 1971 cmꢀ1
.
2.2.1. 1-Methyl-4-(2-pyridyl)-1,2,4-triazolium iodide (L5)
Complex 2b: Yield: 0.07 g (21%). 1H NMR (500 MHz, DMSO-d6,
3
3
A
solution of 4-(2-pyridyl)-1,2,4-triazole [51] (1.00 g,
298 K): d 9.35 (d, 1H, JH–H = 5.5 Hz, 6-H of Py), 8.14 (t, 1H,
3
6.85 mmol) and iodomethane (1.94 g, 13.69 mmol) in acetone
(50 ml) was stirred at 60 °C for 12 h. The reaction mixture was fil-
tered and the precipitate was washed three times with Et2O and
dried in vacuo to obtain a white powder. Yield: 1.68 g (85%). 1H
NMR (500 MHz, DMSO-d6, 298 K): d 10.96 (s, 1H, CH3NCHN), 9.99
JH–H = 7.5 Hz, 5-H of Py), 7.76 (d, 1H, JH–H = 7.5 Hz, 3-H of Py),
7.68 (t, 1H, JH–H = 6.5 Hz, 4-H of Py), 7.61 (s, 1H, 4,5-imidazol-
3
2-ylidene H), 7.47 (s, 1H, 4,5-imidazol-2-ylidene H), 5.80 (d, 1H,
2
2JH–H = 16 Hz, CHH linker), 5.23 (d, 1H, JH–H = 16.5 Hz, CHH lin-
ker), 3.95 (s, 3H, CH3). 13C NMR (DMSO-d6, 125 MHz): d 197.94,
193.39 (CO), 177.82 (Ru–C), 155.34, 154.14, 140.71, 125.06,
124.55, 123.02, 122.65 (Py–C and Ar–C), 54.77 (CH2), 37.92
(CH3). Anal. Calc. for C12H11N3O2Cl2Ru: C, 35.92; H, 2.76; N,
10.47. Found: C, 36.07; H, 2.81; N, 10.32%. FT-IR (KBr, cmꢀ1):
3
(s, 1H, NCHN), 8.70 (d, 1H, JH–H = 4.5 Hz, 6-H of Py), 8.28 (t, 1H,
3JH–H = 6.5 Hz, 5-H of Py), 8.06 (d, 1H, 3J = 8 Hz, 3-H of Py), 7.73–
7.70 (m, 1H, 4-H of Py), 4.18 (s, 3H, CH3). 13C NMR (DMSO-d6,
125 MHz): d 144.81 (CH3NCHN), 139.99 (NCHN), 136.80, 136.54,
136.14, 121.29, 110.45 (Py–C), 34.51 (CH3). Anal. Calc. for
C8H9N4I: C, 33.32; H, 3.12; N, 19.44. Found: C, 33.25; H, 3.03; N,
19.36%.
mCO 2052 and 1979 cmꢀ1
.
2.2.4. {[3-Methyl-1-(2-pyridyl)benzimidazolin-2-ylidene]Ru(CO)2Cl2}
3 (3b)
2.2.2. {[3-Methyl-1-(2-pyridyl)imidazol-2-ylidene]Ru(CO)2Cl2} 1 (1a
and 1b)
A
mixture of L3 (0.20 g, 0.56 mmol), Ru(CO)2Cl2 (0.13 g,
0.56 mmol) and NEt3 (0.31 ml, 2.24 mmol) in 40 ml of CH3CN
was stirred at room temperature until a pale yellow precipitate
was formed. The resulting solid was filtered and then recrystallised
from CH2Cl2/MeOH to give yellow crystals. Yield: 0.09 g (35%). 1H
A mixture of L1 (0.20 g, 0.8 mmol) and silver(I) oxide (0.19 g,
0.8 mmol) in 40 ml of CH2Cl2 was stirred at room temperature
for 24 h under exclusion of light, and then [Ru(CO)2Cl]n (0.18 g,
0.8 mmol) was added. The mixture was stirred for 24 h again.
The resulting solution was filtered through Celite and the solvent
was removed under vacuum, the crude residue was purified by
column chromatography. Elution with CH2Cl2: acetone (10:1)
afforded 1a as a pale yellow solid, and then elution with CH2Cl2:
acetone (5:1) yielded 1b as a yellow solid.
3
NMR (500 MHz, DMSO-d6, 298 K): d 9.42 (d, 1H, JH–H = 5.5 Hz,
3
6-H of Py), 8.66 (d, 1H, JH–H = 8 Hz, Ar-H), 8.52 (d, 1H,
3
3JH–H = 7 Hz, Ar-H), 8.43 (t, 1H, JH–H = 8.5 Hz, 5-H of Py), 8.00 (d,
3
3
1H, JH–H = 8.5 Hz, 3-H of Py), 7.76 (t, 1H, JH–H = 6.5 Hz, 4-H of
Py). 7.66–7.61 (m, 2H, Ar-H), 4.22 (s, 3H, CH3). 13C NMR (DMSO-
d6, 125 MHz): d 197.73, 193.05 (CO), 190.02 (Ru–C), 152.82,
149.33, 143.31, 135.89, 130.55, 125.81, 125.73, 122.89, 114.07,
113.26, 112.89 (Py–C and Ar–C), 35.69 (CH3). Anal. Calc. for
Complex 1a: Yield: 0.10 g (32%). 1H NMR (500 MHz, DMSO-d6,
3
298 K): d 9.03 (d, 1H, JH–H = 5 Hz, 6-H of Py), 8.47 (s, 1H, 4,5-
3
imidazol-2-ylidene H), 8.33 (t, 1H, JH–H = 1.5 Hz, 5-H of Py), 8.25
3
C
15H11N3O2Cl2Ru: C, 41.20; H, 2.54; N, 9.61. Found: C, 41.19; H,
(d, 1H, JH–H = 8 Hz, 3-H of Py), 7.72 (s, 1H, 4,5-imidazol-2-ylidene
2.53; N, 9.53%. FT-IR (KBr, cmꢀ1): mCO 2056 and 1990 cmꢀ1
.
3
H), 7.64 (t, 1H, JH–H = 6 Hz, 4-H of Py), 4.09 (s, 3H, CH3). 13C NMR
(DMSO-d6, 125 MHz):
d 203.38, 196.89 (CO), 190.79 (Ru–C),
156.28, 145.88, 132.06, 128.95, 127.35, 120.53, 116.13 (Py–C and
4,5-imidazol-2-ylidene C), 41.18 (CH3). Anal. Calc. for
2.2.5. {[3-Methyl-1-(2-picoyl)benzimidazolin-2-ylidene]Ru(CO)2Cl2} 4
(4a and 4b)
The complexes were prepared by a procedure analogous to that
for 1a and 1b using the carbene precursor salt L4 (0.20 g,
0.77 mmol), silver(I) oxide (0.18 g, 0.77 mmol) and [Ru(CO)2Cl]n
(0.18 g, 0.77 mmol). Elution with CH2Cl2 initially gave 4a as a pale
C
11H9N3O2Cl2Ru: C, 34.12; H, 2.34; N, 10.85. Found: C, 34.02; H,
2.21; N, 10.72%. FT-IR (KBr, cmꢀ1): mCO 2062 and 1994 cmꢀ1
.
Complex 1b: Yield: 0.09 g (29%). 1H NMR (500 MHz, DMSO-d6,
3
298 K): d 9.23 (d, 1H, JH–H = 5.5 Hz, 6-H of Py), 8.47 (s, 1H, 4,5-
imidazol-2-ylidene H), 8.35 (t, 1H, JH–H = 8.5 Hz, 5-H of Py), 8.23
(d, 1H, JH–H = 8.5 Hz, 3-H of Py), 7.93 (s, 1H, 4,5-imidazol-2-yli-
dene H), 7.69 (t, 1H, JH–H = 6.5 Hz, 4-H of Py), 3.93 (s, 3H, CH3).
3
3
3
Table 1
13C NMR (DMSO-d6, 125 MHz): d 202.88, 195.26(CO), 183.71
(Ru–C), 156.95, 153.62, 147.83, 131.20, 128.01, 122.74, 117.80
(Py–C and 4,5-imidazol-2-ylidene C), 35.91 (CH3). Anal. Calc. for
Selected bond lenghs (Å) and bond angles (°) for complex 1b, 2b, 3b and 4b.
1b
2b
3b
4b
Bond lengths
Ru1–C3
Ru1–N3
Ru1–Cl1
Ru1–Cl2
Ru1–C10
Ru1–C11
C
11H9N3O2Cl2Ru: C, 34.12; H, 2.34; N, 10.85. Found: C, 33.98; H,
2.19; N, 10.68%. FT-IR (KBr, cmꢀ1): mCO 2060 and 1996 cmꢀ1
.
2.014(3)
2.152(2)
2.4538(8)
2.4318(8)
1.874(3)
1.878(3)
2.006(5)
2.002(3)
2.029(2)
2.172(4)
2.4822(11)
2.4262(12)
1.859(5)
1.869(5)
2.132(3)
2.4548(10)
2.4730(10)
1.891(4)
1.884(4)
2.1630(18)
2.4646(6)
2.4279(7)
1.866(3)
1.853(3)
2.2.3. {[3-Methyl-1-(2-picoyl)imidazol-2-ylidene]Ru(CO)2Cl2} 2 (2a
and 2b)
The complexes were prepared, following a procedure similar to
that for 1a and 1b, using the carbene precursor salt L2 (0.20 g,
0.79 mmol), silver(I) oxide (0.18 g, 0.79 mmol) and [Ru(CO)2Cl]n
(0.18 g, 0.79 mmol). Initial elution with CH2Cl2: acetone (30:1)
Bond angles
C10–Ru1–C3
C11–Ru1–C3
C10–Ru1–N3
C11–Ru1–N3
C3–Ru1–N3
C3–Ru1–Cl2
N3–Ru1–Cl2
C3–Ru1–Cl1
N3–Ru1–Cl1
98.88(12)
92.93(11)
174.72(11)
93.92(10)
77.51(10)
90.12(7)
86.69(6)
170.74(8)
93.24(6)
96.8(2)
93.3(2)
93.66(15)
100.94(15)
91.71(14)
176.94(14)
77.40(12)
86.49(10)
88.23(8)
93.96(10)
93.65(10)
176.92(10)
94.14(9)
84.55(8)
91.43(6)
87.67(6)
173.71(7)
89.33(5)
176.54(19)
91.86(18)
85.86(17)
87.31(14)
87.14(11)
176.22(14)
91.50(11)
gave 2a as
a pale yellow solid. Subsequently elution with
CH2Cl2:acetone (10:1) produced 2b as a yellow solid.
Complex 2a: Yield: 0.13 g (40%). 1H NMR (500 MHz, DMSO-d6,
3
298 K): d 9.08 (d, 1H, JH–H = 5.5 Hz, 6-H of Py), 8.14 (t, 1H,
171.25(9)
94.08(8)
3JH–H = 7.5 Hz, 5-H of Py), 7.77 (d, 1H, JH–H = 7.5 Hz, 3-H of Py),
3
3
7.65 (t, 1H, JH–H = 7 Hz, 4-H of Py), 7.58 (s, 1H, 4,5-imidazol-2-